Treatment Response to Conventional and Novel Therapies in Chronic Prostatitis

Overview

Journal Curr Urol Rep

Publisher Current Science

Specialty Urology

Date 2003 Jul 29

PMID 12882725

Citations 4

Authors

Daniel A Shoskes

Affiliations

Soon will be listed here.

Citing Articles

The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update.

Lotfi N, Yousefi Z, Golabi M, Khalilian P, Ghezelbash B, Montazeri M Front Immunol. 2023; 14:1077531.

PMID: 36926328 PMC: 10011078. DOI: 10.3389/fimmu.2023.1077531.

Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Disease or Symptom? Current Perspectives on Diagnosis, Treatment, and Prognosis.

Zhang J, Liang C, Shang X, Li H Am J Mens Health. 2020; 14(1):1557988320903200.

PMID: 32005088 PMC: 7256330. DOI: 10.1177/1557988320903200.

Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.

Ward A, Mir H, Kapur N, Gales D, Carriere P, Singh S World J Surg Oncol. 2018; 16(1):108.

PMID: 29898731 PMC: 6001031. DOI: 10.1186/s12957-018-1400-z.

Sexual dysfunction and prostatitis.

Sadeghi-Nejad H, Seftel A Curr Urol Rep. 2006; 7(6):479-84.

PMID: 17052445 DOI: 10.1007/s11934-006-0058-1.

References

Shahed A, Shoskes D . Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol. 2001; 166(5):1738-41. View

Hollman P, Katan M . Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl. 1998; 20:237-48. DOI: 10.1007/978-3-642-46856-8_21. View

Taylor-Robinson D . Mycoplasma genitalium -- an up-date. Int J STD AIDS. 2002; 13(3):145-51. DOI: 10.1258/0956462021924776. View

de la Rosette J, Karthaus H, Van Kerrebroeck P, de Boo T, Debruyne F . Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol. 1992; 22(3):222-7. DOI: 10.1159/000474760. View

Goto T, Makinose S, Ohi Y, Yamauchi D, Kayajima T, Nagayama K . Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate. Int J Urol. 1998; 5(3):243-6. DOI: 10.1111/j.1442-2042.1998.tb00597.x. View

Neal Jr D, Moon T . Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology. 1994; 43(4):460-5. DOI: 10.1016/0090-4295(94)90231-3. View

RUGENDORFF E, Weidner W, Ebeling L, Buck A . Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol. 1993; 71(4):433-8. DOI: 10.1111/j.1464-410x.1993.tb15988.x. View

Turner J, Ciol M, Von Korff M, Berger R . Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 2003; 169(2):580-3. DOI: 10.1097/01.ju.0000047620.95034.a5. View

Canale D, Scaricabarozzi I, Giorgi P, Turchi P, Ducci M . Use of a novel non-steroidal anti-inflammatory drug, nimesulide, in the treatment of abacterial prostatovesiculitis. Andrologia. 1993; 25(3):163-6. DOI: 10.1111/j.1439-0272.1993.tb02701.x. View

10.

Shoskes D, Zeitlin S . Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis. Prostate Cancer Prostatic Dis. 2002; 2(3):159-162. DOI: 10.1038/sj.pcan.4500308. View

11.

Jimenez-Cruz J, Tormo F, Gomez J . Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control. J Urol. 1988; 139(5):967-70. DOI: 10.1016/s0022-5347(17)42733-9. View

12.

Sato M, Miyazaki T, Kambe F, Maeda K, Seo H . Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol. 1997; 24(9):1680-4. View

13.

Shoskes D, Hakim L, Ghoniem G, Jackson C . Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2003; 169(4):1406-10. DOI: 10.1097/01.ju.0000055549.95490.3c. View

14.

Yavascaoglu I, Camlikiyi H, Oktay B, Simsek , Ozyurt M . Percutaneous suprapubic transvesical route: a new and comfortable method of intraprostatic injection. Urol Int. 1998; 60(4):229-34. DOI: 10.1159/000030261. View

15.

Weidner W, Ludwig M, Brahler E, SCHIEFER H . Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs. 1999; 58 Suppl 2:103-6. DOI: 10.2165/00003495-199958002-00021. View

16.

Lacquaniti S, Destito A, Servello C, Candidi M, Weir J, Brisinda G . Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study. Arch Ital Urol Androl. 2000; 71(5):283-5. View

17.

Barza M, Cuchural G . The penetration of antibiotics into the prostate in chronic bacterial prostatitis. Eur J Clin Microbiol. 1984; 3(6):503-5. DOI: 10.1007/BF02013607. View

18.

Yavascaoglu I, Oktay B, Simsek U, Ozyurt M . Role of ejaculation in the treatment of chronic non-bacterial prostatitis. Int J Urol. 1999; 6(3):130-4. DOI: 10.1046/j.1442-2042.1999.06338.x. View

19.

Mayo M, Ross S, Krieger J . Few patients with "chronic prostatitis" have significant bladder outlet obstruction. Urology. 1998; 52(3):417-21. DOI: 10.1016/s0090-4295(98)00202-7. View

20.

Litwin M . A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology. 2003; 60(6 Suppl):14-8; discussion 18-9. DOI: 10.1016/s0090-4295(02)02296-3. View